Advertisement
Person › Details
Vered Caplan (Orgenesis Inc. (Nasdaq: ORGS))
Caplan, Vered (Orgenesis 201512 CEO)
Organisation | Orgenesis Inc. (Nasdaq: ORGS) | |
Group | Orgenesis (Group) | |
Product | antidiabetic | |
Product 2 | cell therapy | |
Record changed: 2021-11-29 |
Advertisement
More documents for Vered Caplan
- [1] Orgenesis Inc.. (11/29/21). "Press Release: Orgenesis and Theracell Joint Venture to Receive up to €32 Million From Greek Government to Accelerate Rollout of POCare Centers and Deployment of OMPULs". Germantown, MD....
- [2] MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX....
- [3] Orgenesis Inc.. (1/22/18). "Press Release: Orgenesis Announces a Strategic Corporate Regrouping of its CDMO Activities Under the Global MaSTherCell Brand & Service Offerings Alignment". Germantown, MD....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top